This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

GEORGE V. KULCHAR, M.D.; CHARLES W. BARNETT, M.D.; JOHN F. CARD, M.D.

Arch Derm Syphilol. 1940;42(1):46-52.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

After many years of experimental search for a preparation which would produce a significant concentration of bismuth in the central nervous system, Hanzlik, Mehrtens, Gurchot and Johnson¹ introduced iodobismitol (sodium iodobismuthite dissolved in ethylene glycol containing 12 per cent sodium iodide) in 1930. The administration of this preparation to animals resulted in greater amounts of bismuth in the nervous system than were obtained with other available compounds. These findings suggested that iodobismitol might be of exceptional value in the treatment of neurosyphilis, and this theoretic effectiveness was supported by the preliminary clinical studies of Mehrtens and Pouppirt.² No further clinical evaluation of this preparation in the treatment of neurosyphilis has been made, although Johnson and Barnett³ have shown that its use in the routine treatment of early syphilis does not prevent involvement of the nervous system.

Thorough investigation in the laboratory is essential before any drug may . . . [Full Text PDF of this Article]

Author Affiliations
SAN FRANCISCO

From the Department of Medicine, Stanford University School of Medicine.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?